Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia
Journal of Gastroenterology · 2026
DOI: 10.1007/s00535-026-02489-z ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Yosuke Otsuka und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. Hauptthemen laut MEDLINE: Thrombocytopenia, Thiazoles, Liver Diseases, Thiophenes. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This multicenter retrospective study evaluated the efficacy and safety of avatrombopag (AVA) in Japanese patients with chronic liver disease (CLD) and severe thrombocytopenia in a real-world clinical setting. METHODS: The study included CLD patients with platelet counts 68 kg as the only significant factor associated with platelet count increase < 20,000/μL. Platelet-increasing effects did not differ by TPO-RA administration history. No adverse events, including portal vein thrombosis or hemorrhagic events, occurred. CONCLUSIONS: While interpretation requires caution due to the small sample size, in Japanese real-world practice, AVA was relatively safe and effective in preventing perioperative bleeding and avoiding platelet transfusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Gastroenterology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
- Department of Medicine, Division of Gastroenterology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. morimoto@jichi.ac.jp.
- Department of Clinical Research, NHO Takasaki General Medical Center, Takasaki, Japan.
- Department of Internal Medicine, Division of Gastroenterology, Ibaraki Medical Center, Tokyo Medical University, Ami, Japan.
- Department of Gastroenterology, Dokkyo Medical University, Mibu, Japan.
- Department of Gastroenterology, Maebashi Red Cross Hospital, Maebashi, Japan.
Zitieren
APA
Otsuka, Y., Morimoto, N., Kakizaki, S., Ikegami, T., Watanabe, S., Majima, Y., Arai, H., Asano, T., Uchida, Y., Kamoshida, T., Hatanaka, T., Takakusagi, S., Nihei, T., Soeda, A., Yamazaki, Y., Hasegawa, N., Kurata, H., Suga, T., Tahara, T., …, & Liver Investigators in Northern Kanto Study (LINKS) Group (2026). Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02489-z
Vancouver
Otsuka Y, Morimoto N, Kakizaki S, Ikegami T, Watanabe S, Majima Y, et al. Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02489-z
BibTeX
@article{Otsuka2026,
author = {Otsuka, Yosuke and Morimoto, Naoki and Kakizaki, Satoru and Ikegami, Tadashi and Watanabe, Shunji and Majima, Yuichi and Arai, Hirotaka and Asano, Takeharu and Uchida, Yoshihito and Kamoshida, Toshiro and Hatanaka, Takeshi and Takakusagi, Satoshi and Nihei, Takeshi and Soeda, Atsuko and Yamazaki, Yuichi and Hasegawa, Naoyuki and Kurata, Hidekazu and Suga, Takayoshi and Tahara, Toshiyuki and Goka, Rie and Tsukui, Mamiko and Ueno, Wataru and Miura, Kouichi and Yano, Tomonori and Mochida, Satoshi and Liver Investigators in Northern Kanto Study (LINKS) Group, Liver Investigators in Northern Kanto Study (LINKS) Group},
title = {Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02489-z}
}
EUVIMED